SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025060
Filing Date
2021-05-06
Accepted
2021-05-06 16:37:52
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-10q_20210331.htm   iXBRL 10-Q 2038280
2 EX-31.1 asmb-ex311_10.htm EX-31.1 18195
3 EX-31.2 asmb-ex312_9.htm EX-31.2 18146
4 EX-32.1 asmb-ex321_12.htm EX-32.1 8022
5 EX-32.2 asmb-ex322_8.htm EX-32.2 8115
  Complete submission text file 0001564590-21-025060.txt   8373956

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA asmb-20210331.xsd EX-101.SCH 53216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20210331_cal.xml EX-101.CAL 48129
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20210331_def.xml EX-101.DEF 180098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20210331_lab.xml EX-101.LAB 388524
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20210331_pre.xml EX-101.PRE 322254
11 EXTRACTED XBRL INSTANCE DOCUMENT asmb-10q_20210331_htm.xml XML 1853976
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 21898489
SIC: 2834 Pharmaceutical Preparations